The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garner, R.
Right arrow Articles by McElhaney, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garner, R.
Right arrow Articles by McElhaney, J. E.

The Journal of Immunology, Vol 153, Issue 12 5413-5421, Copyright © 1994 by American Association of Immunologists


ARTICLES

Characterization of a granule-independent lytic mechanism used by CTL hybridomas

R Garner, CD Helgason, EA Atkinson, MJ Pinkoski, HL Ostergaard, O Sorensen, A Fu, PH Lapchak, A Rabinovitch and JE McElhaney
Department of Biochemistry, University of Alberta, Edmonton, Canada.

The mechanism(s) by which CTL induce target cell lysis have not been clearly elucidated. Perforin and the cytotoxic cell proteinases (granzymes) contained within the granules of CTL and NK, have been implicated, but abundant evidence for the existence of alternate lytic pathways has accumulated. In this report we characterize the mechanism of killing used by two cytolytic hybridomas (PMM-1 and MD90) that express neither perforin nor the granzymes. These characteristics are compared with results obtained by using a representative Ag-dependent, granule-containing T cell clone in cytolysis assays. The major differences were that the granule-negative hybridomas could lyse a variety of target cells in the presence of cyclosporin and the absence of calcium. All the effectors could kill in the presence of protein synthesis inhibitors (cycloheximide and emetine) and induced DNA fragmentation in the target cells. The cytolytic hybridomas had to be stimulated to be cytolytic and this activation required the presence of calcium, was dependent on protein synthesis, and inhibited by the addition of cyclosporin. Although TNF was shown not be involved, the sensitivity of the target cells to lysis by the granule-negative killers correlated with the level of expression of Fas Ag. With the use of L1210 and an L1210 cell line transfected with Fas cDNA we demonstrated that these MD90 and PMM-1 kill the latter much more effectively and that this increase was effectively inhibited with anti- Fas Ab. Furthermore the lack of sensitivity to cyclosporin, cycloheximide, emetine, and EGTA was confirmed with these targets. We conclude that these two cytolytic hybridomas use the Fas lytic pathway to induce lysis in target cells.


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
K. Veugelers, B. Motyka, I. S. Goping, I. Shostak, T. Sawchuk, and R. C. Bleackley
Granule-mediated Killing by Granzyme B and Perforin Requires a Mannose 6-Phosphate Receptor and Is Augmented by Cell Surface Heparan Sulfate
Mol. Biol. Cell, February 1, 2006; 17(2): 623 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Dressel, S. M. Raja, S. Honing, T. Seidler, C. J. Froelich, K. von Figura, and E. Gunther
Granzyme-mediated Cytotoxicity Does Not Involve the Mannose 6-Phosphate Receptors on Target Cells
J. Biol. Chem., May 7, 2004; 279(19): 20200 - 20210.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Mitsui, Y. Miyake, H. Kakeya, H. Osada, and T. Kataoka
ECH, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity
J. Immunol., March 15, 2004; 172(6): 3428 - 3436.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Frost, L. H. Butterfield, V. B. Dissette, J. S. Economou, and B. Bonavida
Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures
J. Immunol., March 1, 2001; 166(5): 3564 - 3573.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Barry, J. A. Heibein, M. J. Pinkoski, S.-F. Lee, R. W. Moyer, D. R. Green, and R. C. Bleackley
Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid
Mol. Cell. Biol., June 1, 2000; 20(11): 3781 - 3794.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. N. Orlov, N. Thorin-Trescases, S. V. Kotelevtsev, J. Tremblay, and P. Hamet
Inversion of the Intracellular Na+/K+ Ratio Blocks Apoptosis in Vascular Smooth Muscle at a Site Upstream of Caspase-3
J. Biol. Chem., June 4, 1999; 274(23): 16545 - 16552.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Fuller and V. L. Braciale
Selective Induction of CD8+ Cytotoxic T Lymphocyte Effector Function by Staphylococcus Enterotoxin B
J. Immunol., November 15, 1998; 161(10): 5179 - 5186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Atkinson, M. Barry, A. J. Darmon, I. Shostak, P. C. Turner, R. W. Moyer, and R. C. Bleackley
Cytotoxic T Lymphocyte-assisted Suicide. CASPASE 3 ACTIVATION IS PRIMARILY THE RESULT OF THE DIRECT ACTION OF GRANZYME B
J. Biol. Chem., August 14, 1998; 273(33): 21261 - 21266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Darmon and R. C. Bleackley
An Interleukin-1beta Converting Enzyme-like Protease Is a Key Component of Fas-mediated Apoptosis
J. Biol. Chem., September 6, 1996; 271(36): 21699 - 21702.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Darmon, T. J. Ley, D. W. Nicholson, and R. C. Bleackley
Cleavage of CPP32 by Granzyme B Represents a Critical Role for Granzyme B in the Induction of Target Cell DNA Fragmentation
J. Biol. Chem., September 6, 1996; 271(36): 21709 - 21712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.